Farmaco. 2001 Jan-Feb;56(1-2):77-80.

A1 adenosine receptors and their ligands: overview and recent developments.

Source

University of Bonn, Pharmaceutical Institute, Department of Pharmaceutical Chemistry, Germany. christa.mueller@uni-bonn.de

Abstract

Potent adenosine receptor (AR) agonists and antagonists with high selectivity for the A1AR subtype have been developed during the past decades. However, some of the compounds considered to be selective may not be as selective in humans as in rats, and may not be very selective versus the new AR subtypes A3 or A2B. Partial agonists have been developed that may exhibit fewer side effects than full agonists. Low water solubility of many A1 antagonists remains a problem. A1 AR antagonists can be classified as neutral antagonists or inverse agonists; the pharmacological consequences of inverse agonism versus neutral antagonism will have to be the subject of future investigations. Some medicinal plants (e.g. Hypericum perforatum and Valeriana officinalis) contain compounds that are antagonists or partial agonists at A1 ARs; effects on ARs may contribute to their pharmacological activity. 18F- and 11C-labeled A1 AR antagonists have been developed for positron emission tomography studies.

PMID:: 11347971; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

Review Medicinal chemistry of adenosine A3 receptor ligands. [Curr Top Med Chem. 2003]
Review Medicinal chemistry of adenosine A3 receptor ligands.
Müller CE. Curr Top Med Chem. 2003; 3(4):445-62.
1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. [J Med Chem. 2002]
1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM, Sandoval-Ramírez J, Reith U, Schobert U, Preiss B, Schumacher B, Daly JW, Müller CE. J Med Chem. 2002 Mar 28; 45(7):1500-10.
2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors. [Bioorg Med Chem. 2003]
2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.
Ozola V, Thorand M, Diekmann M, Qurishi R, Schumacher B, Jacobson KA, Müller CE. Bioorg Med Chem. 2003 Feb 6; 11(3):347-56.
Review Adenosine receptors and their ligands. [Naunyn Schmiedebergs Arch Phar...]
Review Adenosine receptors and their ligands.
Klotz KN. Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov; 362(4-5):382-91.
Review Adenosine receptor ligands-recent developments part I. Agonists. [Curr Med Chem. 2000]
Review Adenosine receptor ligands-recent developments part I. Agonists.
Muller CE. Curr Med Chem. 2000 Dec; 7(12):1269-88.

See reviews... See all...

Cited by 1 PubMed Central article

Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist. [Br J Pharmacol. 2006]
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.
Heitman LH, Mulder-Krieger T, Spanjersberg RF, von Frijtag Drabbe Künzel JK, Dalpiaz A, IJzerman AP. Br J Pharmacol. 2006 Mar; 147(5):533-41.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A1 adenosine receptors and their ligands: overview and recent developments.
A1 adenosine receptors and their ligands: overview and recent developments.
Farmaco. 2001 Jan-Feb ;56(1-2):77-80.

PubMed
No effect of verapamil on the local bone response to in vivo mechanical loading.
No effect of verapamil on the local bone response to in vivo mechanical loading.
J Orthop Res. 2001 Mar ;19(2):328-36.

PubMed
Black cohosh: efficacy, safety, and use in clinical and preclinical applications...
Black cohosh: efficacy, safety, and use in clinical and preclinical applications.
Altern Ther Health Med. 2001 May-Jun ;7(3):93-100.

PubMed
A randomized clinical trial on the treatment of oral herpes with topical zinc ox...
A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine.
Altern Ther Health Med. 2001 May-Jun ;7(3):49-56.

PubMed
Trabeculectomy: a re-evaluation after three years and a comparison with Scheie's...
Trabeculectomy: a re-evaluation after three years and a comparison with Scheie's procedure.
Ophthalmic Surg. 1975 Spring ;6(1):27-38.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: